Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
6.95M
-
Shares change
-
+1.8M
-
Total reported value, excl. options
-
$69.6M
-
Value change
-
+$18M
-
Number of buys
-
11
-
Price
-
$9.97
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2017
14 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q4 2017.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.95M shares
of 27.7M outstanding shares and own 25.09% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), 683 Capital Management, LLC (867K shares), Opaleye Management Inc. (847K shares), EVENTIDE ASSET MANAGEMENT, LLC (741K shares), ACUTA CAPITAL PARTNERS, LLC (250K shares), PUTNAM INVESTMENTS LLC (118K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (59K shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (52.8K shares), Cardinal Capital Management (12K shares), and Hartford Financial Management Inc. (2.15K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.